With semaglutide and tirzepatide dosed once weekly, their estimated average yearly costs in the U.S. are $14,080 and $8,126, ...

In adults with obesity and prediabetes, weight loss achieved with tirzepatide was sustained at more than 3 years, according ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.

Researchers found that once-monthly maridebart cafraglutide led to substantial weight loss and improved glycemic control in ...

GPs in England will be able to prescribe weight loss jabs for the first time on the NHS on Monday, as the health service ...

About 82% of participants taking tirzepatide experienced 5% or greater weight loss. In comparison, only 66.5% of participants taking semaglutide achieved this level of weight loss. Which one to choose ...

How tirzepatide works for weight loss. Tirzepatide is a type of medication known as a GLP-1 agonist, which means it mimics a naturally-occurring hormone in the body called a peptide to influence a ...

Compare tirzepatide and semaglutide for weight loss effectiveness, side effects and cost. Learn which medication is the better choice for you.

An injection drug known as tirzepatide, already approved by the FDA for treating Type 2 diabetes, is likely to gain approval for weight loss treatment this year. Here's what to know.

Prescriptions for tirzepatide injections will not be available from GP surgeries or pharmacies in East and North Yorkshire – ...

Tirzepatide, a new drug that could have far-reaching impact — and billions in sales — is likely to be approved for weight loss by the Food and Drug Administration in 2023.